HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Reaction

Acetic Acid → 3-(2-((2H-1,2,3-Triazol-4-yl)amino)-5-chlorobenzyl)cyclobutanecarboxylic acid

HRID 1519142
Print

Reaction equation

HRID 1519142 reaction equation
C([N:8]1[C:12]([NH:13][C:14]2[CH:27]=[CH:26][C:25]([Cl:28])=[CH:24][C:15]=2[CH:16]=[C:17]2[CH2:20][CH:19]([C:21]([OH:23])=[O:22])[CH2:18]2)=[CH:11][N:10]=[N:9]1)C1C=CC=CC=1.C(O)(=O)C>CCOC(C)=O.CO.Br[Zn]Br.[Pd]>[N:10]1[NH:9][N:8]=[C:12]([NH:13][C:14]2[CH:27]=[CH:26][C:25]([Cl:28])=[CH:24][C:15]=2[CH2:16][CH:17]2[CH2:20][CH:19]([C:21]([OH:23])=[O:22])[CH2:18]2)[CH:11]=1
ParticipantsProcedureWorkupSources & evidenceReaction notes

Participants

7

Reactant 2

HCID 176Acetic Acid2×HCID 867240613-(2-((1-benzyl-1H-1,2,3-triazol-5-yl)amino)-5-chlorobenzylidene)cyclobutanecarboxylic acid

Product 1

HCID 752029263-(2-((2H-1,2,3-Triazol-4-yl)amino)-5-chlorobenzyl)cyclobutanecarboxylic acidYield 3.9%

Reagents, catalysts & solvents 4

HCID 23938PalladiumCatalyst
HCID 24375
Zinc bromide (ZnBr2); Zinc Dibromide
Catalyst
HCID 887MethanolSolvent
HCID 8857Ethyl AcetateSolvent

Procedure

To a solution of 3-(2-((1-benzyl-1H-1,2,3-triazol-5-yl)amino)-5-chlorobenzylidene)cyclobutanecarboxylic acid 7 g (75 mg, 0.19 mmol) and dibromozinc (17.1 mg, 0.076 mmol) in EtOAc (2 mL) and MeOH (2 mL) was added 10% Pd on C [wet Degussa type] (40 mg, 0.038 mmol). The reaction was then flushed with hydrogen via vacuum/hydrogen cycles (3×) and the mixture stirred under a hydrogen atmosphere for 2 h at room temperature. Additional 10% Pd on C [wet Degussa type] (40 mg, 0.038 mmol) was added and stirred under hydrogen for a further 1 h. Acetic acid (23 mg, 21.60 μL, 0.38 mmol) was then added and mixture stirred under hydrogen overnight. Additional acetic acid (22 mg, 21.60 μL, 0.38 mmol) was added and stirred under hydrogen atmosphere again overnight. The reaction mixture was then filtered through celite washing through with methanol. The filtrate was concentrated and the material purified by FractionLynx to afford the title compound I-28 as a white solid (1.5 TFA salt) (4.0 mg, 3.9% yield). 1H NMR (500 MHz, d6-DMSO) δ 7.78 (1H, brs), 7.59 (1H, brs), 7.46 (1H, brs), 7.10-7.12 (1H, m), 7.06 (1H, d), 2.87-2.94 (1H, m), 2.72 (2H, d), 2.50-2.55 (1H, masked signal), 2.18-2.25 (2H, m), 1.84-1.90 (2H, m). MS m/z: 307.1 (M+H)+.

Workup

  1. customThe reaction was then flushed with hydrogen via vacuum/hydrogen cycles (3×)
  2. additionAdditional 10% Pd on C [wet Degussa type] (40 mg, 0.038 mmol) was added
  3. stirringstirred under hydrogen for a further 1 h
  4. stirringmixture stirred under hydrogen overnight
  5. stirringstirred under hydrogen atmosphere again overnight
  6. filtrationThe reaction mixture was then filtered through celite
  7. washwashing through with methanol
  8. concentrationThe filtrate was concentrated
  9. customthe material purified by FractionLynx

Sources & evidence

ORD record
ord-0d87f2c1ae944850834697c7746a734e
Source dataset
uspto-grants-2015_07
DOI
10.6084/m9.figshare.5104873.v1
Patent number
US09073875B2

Reaction notes

On this pageParticipantsProcedureWorkupSources & evidenceReaction notes